XML 39 R26.htm IDEA: XBRL DOCUMENT

Transactions With Related Parties	12 Months Ended
Transactions With Related Parties	Dec. 31, 2016
Transactions With Related Parties [Abstract]
Transactions With Related Parties	19. Transactions with Related Parties A member of the Company’s Board of Directors and a shareholder of the Company is an employee of an investment banking services company. On January 20, 2016 CryoLife acquired On-X. The investment banking company represented On-X in that acquisition, for which they earned $3.0 million in fees upon the close of the acquisition. CryoLife paid these fees directly to the investment banking company on behalf of On-X out of the proceeds of the acquisition. The Company made stock repurchases of $5.6 million 2014 which includes the cost of stock and commissions of less than 1% to that investment banking services company. The Company did not make any stock repurchases in 2015 or 2016. A member of the Company’s Board of Directors and a shareholder of the Company was the former Chief of Thoracic Surgery of a university hospital that generated product and preservation services revenues of $316,000, $329,000, and $273,000 for the Company in 2016, 2015, and 2014, respectively. Additionally, the son of this member of the Company’s Board of Directors receives a retainer for performing heart and lung transplants from a medical center that generated product and preservation services revenues of $479,000, $617,000, and $616,000 for the Company in 2016, 2015, and 2014, respectively. The Company expensed $39,000, $35,000, and $45,000 in 2016, 2015, and 2014, respectively, relating to supplies for clinical trials purchased from a company whose former Chief Financial Officer is a member of the Company's Board of Directors and a shareholder of the Company. The Company expensed $44,000 and $43,000 in 2016 and 2015, respectively, relating to membership fees to a medical device trade association where the Company’s President and CEO is a current member of the Board of Directors.